Free Communications: 2

28 Jan 2020
11:50-13:10
Hall 11
Back

Free Communications: 2

Chairs: Andy Sims & David Miles

1)
Pathological features and outcome of screen detected ductal carcinoma in situ (DCIS):  Updated analysis from the UK Sloane Project
Abeer M Shaaban et al

2)
Fulvestrant plus capivasertib versus placebo in metastatic ER positive breast cancer (FAKTION): A randomised, double-blind, placebo-controlled, phase II trial
Sacha Jon Howell et al

3)
Results from plasmaMATCH: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer
Alistair Ring et al

4)
Whole-genome-sequencing of triple negative breast cancers in a standard population-based clinical setting Johan Staaf et al

5)
A 3D-printed electrochemical sensor for measuring reactive oxygen/nitrogen species production from breast cancer cells and ex vivo-cultured tumour tissue
William E Jones et al